Abstract
Background: Type 1 diabetes mellitus (T1D) is a chronic disease that requires exogenous insulin administration and intensive management to prevent any complications. Recent innovations in T1D management technologies include the Advanced Hybrid Closed-Loop delivery system (AHCL). The pioneer AHCL system provides automated basal and automated bolus corrections when needed.
Objective: This study aimed to compare the Advanced Hybrid Closed-Loop (AHCL) system and the Sensor-Augmented Pump (SAP) with Predictive Low Glucose Management (PLGM) system, in relation to glycaemic outcomes, general and diabetes-related Quality of Life (QoL), and diabetes distress.
Methods: General and diabetes-related QoL were assessed with the Diabetes Quality of Life Brief Clinical Inventory (DQOL-BCI) and the World Health Organization Quality of Life-BREF (WHOQOL-BREF), respectively. Diabetes distress was assessed with the Diabetes Distress Scale for Type 1 diabetes (T1-DDS).
Results: Eighty-nine T1D adults participated in the study, mostly females (65.2%), with a mean age of 39.8 (± 11.5 years). They had on average 23 years of diabetes (± 10.7) and they were on continuous subcutaneous insulin infusion therapy. Significant differences favoring the AHCL over the SAP + PLGM system were demonstrated by lower mean glucose levels, less time above range, lower scores on DQOL-BCI, T1-DDS, and higher scores on WHOQOL-BREF. Finally, the linear regression models revealed the association of time in range in most of the above aspects.
Conclusion: This study highlighted the advantages of the AHCL system over the SAP + PLGM system in the real-world setting in relation to general and diabetes-related QoL, diabetes distress, and glycaemic outcomes.
Keywords: Type 1 diabetes mellitus, advanced hybrid closed-loop, sensor-augmented pump, quality of life, glycaemic outcomes, diabetes distress.
[http://dx.doi.org/10.2337/dc23-S002] [PMID: 36507649]
[http://dx.doi.org/10.1016/j.drudis.2009.06.011] [PMID: 19580883]
[http://dx.doi.org/10.1615/CritRevImmunol.2019033126] [PMID: 32421967]
[http://dx.doi.org/10.2174/1573399817666210614113827] [PMID: 35546329]
[http://dx.doi.org/10.1007/s13300-021-01157-0] [PMID: 34596879]
[http://dx.doi.org/10.1007/s00592-022-01929-5] [PMID: 35994106]
[PMID: 35619270]
[http://dx.doi.org/10.1016/j.diabres.2018.09.008] [PMID: 30218744]
[http://dx.doi.org/10.3390/healthcare8010025] [PMID: 32019118]
[http://dx.doi.org/10.1111/dom.14714] [PMID: 35403792]
[http://dx.doi.org/10.3389/fendo.2021.766314] [PMID: 34858339]
[http://dx.doi.org/10.1016/j.diabres.2022.110052] [PMID: 36030902]
[http://dx.doi.org/10.2337/dc23-S007] [PMID: 36507635]
[PMID: 30559233]
[http://dx.doi.org/10.2174/1573399818666211103163208] [PMID: 34732118]
[http://dx.doi.org/10.1517/17425247.2016.1115013] [PMID: 26618219]
[http://dx.doi.org/10.1007/s00592-013-0466-x] [PMID: 23508374]
[http://dx.doi.org/10.1111/j.1464-5491.2007.02346.x] [PMID: 18201210]
[http://dx.doi.org/10.1016/j.diabres.2020.108026] [PMID: 31954749]
[http://dx.doi.org/10.2337/diaspect.17.1.41]
[http://dx.doi.org/10.1016/j.jdiacomp.2015.01.012] [PMID: 25765489]
[http://dx.doi.org/10.22365/jpsych.2020.314.302] [PMID: 33361060]
[http://dx.doi.org/10.1017/S0033291798006667] [PMID: 9626712]
[PMID: 22796911]
[http://dx.doi.org/10.1007/s11892-015-0644-z] [PMID: 26338287]
[http://dx.doi.org/10.1016/j.numecd.2022.03.031] [PMID: 35599092]
[http://dx.doi.org/10.1007/s11892-015-0694-2] [PMID: 26748793]
[http://dx.doi.org/10.1016/j.diabres.2022.109998] [PMID: 35853530]
[http://dx.doi.org/10.1111/dme.14944] [PMID: 36004676]
[http://dx.doi.org/10.2337/dc23-S006] [PMID: 36507646]
[http://dx.doi.org/10.1016/j.diabres.2021.108986] [PMID: 34329691]
[http://dx.doi.org/10.2337/dc20-2250] [PMID: 33579715]
[http://dx.doi.org/10.1007/s00592-022-01886-z] [PMID: 35451679]
[http://dx.doi.org/10.1089/dia.2021.0319] [PMID: 34694909]
[http://dx.doi.org/10.1007/s00592-022-01937-5] [PMID: 35857108]
[http://dx.doi.org/10.1089/dia.2017.0087] [PMID: 28700272]
[http://dx.doi.org/10.1016/j.amjms.2019.07.003] [PMID: 31402042]